Consumer Protection

Report | NJPIRG Law & Policy Center | Public Health, Consumer Protection

Trouble in Toyland

The 2013 Trouble in Toyland report is the 28th annual NJPIRG survey of toy safety. In this report, NJPIRG provides safety guidelines for consumers when purchasing toys for small children and provides examples of toys currently on store shelves that may pose potential safety hazards. 

News Release | NJPIRG | Consumer Protection, Financial Reform

GOOD NEWS FOR CONSUMERS AND FIRMS THAT WANT TO PLAY FAIR

"Today’s confirmation of Richard Cordray to head the CFPB for a full term is good news for consumers, and for firms that want to play fair in the financial marketplace."  

Twenty Top Generic Drugs Delayed By Industry Payoffs

New Jerseyans with cancer, heart disease, epilepsy and other conditions have been forced to pay an average of 10 times more than necessary for at least 20 blockbuster drugs. Brand drug manufacturers have made $98 billion in total sales off the drugs while the generic versions were delayed.

Top Twenty Pay-For-Delay Drugs

Too often, consumers are forced to shoulder a heavy financial burden, or even go without needed medicine, due to the high cost of brand-name drugs. Our research indicates that one significant cause is the practice called “pay for delay,” which inflates the drug prices paid by tens of millions of Americans. 

New Report Documents A Decade Of Safety Violations By Compounding Pharmacies

The contaminated drug that caused last fall’s fungal meningitis outbreak, killing 55 people nation-wide and sickening 51 New Jerseyans, is just the tip of the iceberg of an industry-wide problem, according to a new report released today by NJPIRG.

Prescription For Danger

The fungal meningitis outbreak caused by contaminated steroid injections that killed 55 people to date and sickened more than 740 is one of the worst public health disasters the nation has seen in recent history. The tainted injections came from a drug manufacturer doing business as a “compounding pharmacy,” a classification which allowed them to evade the system of safety rules, inspections, and oversight that keep our drug supply safe.

Everyone knows prescription drugs cost more than they should. But many people are surprised to learn about one of the key ways drug companies keep prices high:  Paying off competitors to keep generics off the market. On Monday, the Supreme Court heard arguments in a case about this very practice.

News Release | NJPIRG Law & Policy Center | Consumer Protection, Food

FDA Protects Public by Releasing Two Long-Delayed Food Safety Rules

Statement of Jennifer Kim, NJPIRG State Director, on the FDA’s proposed new rules for food safety.

Pages

Subscribe to RSS - Consumer Protection

Support Us

Your donation supports NJPIRG's work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

CONSUMER ALERTS

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.
Optional Member Code



NJPIRG is part of The Public Interest Network, which operates and supports organizations committed to a shared vision of a better world and a strategic approach to social change.